http://ssf.f15ijp.com/wiki/index.php?title=Template:Sympatholytic_antihypertensives&feed=atom&action=history
Template:Sympatholytic antihypertensives - Revision history
2024-03-28T22:52:49Z
Revision history for this page on the wiki
MediaWiki 1.26.2
http://ssf.f15ijp.com/wiki/index.php?title=Template:Sympatholytic_antihypertensives&diff=18336&oldid=prev
Jontas: 1 revision: Drug templates from wikipedia
2010-09-19T10:10:55Z
<p>1 revision: Drug templates from wikipedia</p>
<table class='diff diff-contentalign-left'>
<tr style='vertical-align: top;' lang='en'>
<td colspan='1' style="background-color: white; color:black; text-align: center;">← Older revision</td>
<td colspan='1' style="background-color: white; color:black; text-align: center;">Revision as of 10:10, 19 September 2010</td>
</tr><tr><td colspan='2' style='text-align: center;' lang='en'><div class="mw-diff-empty">(No difference)</div>
</td></tr></table>
Jontas
http://ssf.f15ijp.com/wiki/index.php?title=Template:Sympatholytic_antihypertensives&diff=18335&oldid=prev
24.147.91.115 at 15:45, 9 June 2010
2010-06-09T15:45:19Z
<p></p>
<p><b>New page</b></p><div>{{Navbox<br />
| name = Sympatholytic antihypertensives<br />
| title = [[Sympatholytic]] (and closely related) [[antihypertensive]]s ([[ATC code C02|C02]])<br />
| groupstyle = background:MistyRose;<br />
<br />
| group1 = [[Sympatholytic]]s<BR>(antagonize [[Adrenergic_receptor#.CE.B1_receptors|α-adrenergic]]<BR>[[vasoconstriction]])<br />
| list1 = {{Navbox subgroup<br />
| groupstyle = background:MistyRose;<br />
<br />
| group1 = Central<br />
| list1 = {{Navbox subgroup<br />
| groupstyle = background-color: MistyRose;<br />
<br />
| group1 = [[Alpha-adrenergic agonist#.CE.B12 agonists|α<sub>2</sub> agonist]]<br />
| list1 = [[Clonidine]] • [[Guanfacine]] • [[Methyldopa]] #<br />
<br />
| group2 = Adrenergic release inhibitors<br />
| list2 = [[Bethanidine]] • [[Bretylium]] • [[Debrisoquine]] • [[Guanadrel]] • [[Guanazodine]] • [[Guanethidine]] • [[Guanoclor]] • [[Guanoxan]] • [[Guanazodine]] • [[Guanoxabenz]] • [[Guanoxan]]<br />
<br />
| group3 = [[Imidazoline receptor]] agonist<br />
| list3 = [[Moxonidine]] • [[Rilmenidine]]<br />
<br />
| group4 = [[Ganglionic blocker|Ganglion-blocking]]/[[nicotinic antagonist]]<br />
| list4 = [[Mecamylamine]] • [[Pentolinium]] • [[Trimethaphan]]<br />
<br />
}}<br />
<br />
| group2 = Peripheral<br />
| list2 = {{Navbox subgroup<br />
| groupstyle = background-color: MistyRose;<br />
<br />
| group1 = Indirect <br />
| list1 = {{Navbox subgroup<br />
| groupstyle = background-color: MistyRose;<br />
<br />
| group1 = [[Monoamine oxidase inhibitor|MAOI]]<br />
| list1 = [[Pargyline]]<br />
<br />
| group2 = [[Norepinephrine reuptake inhibitor|Adrenergic uptake inhibitor]]<br />
| list2 = [[Rescinnamine]] • [[Reserpine]]<br />
<br />
| group3 = [[Tyrosine hydroxylase inhibitor]]<br />
| list3 = [[Metirosine]]<br />
<br />
}}<br />
<br />
| group2 = Direct<br />
| list2 = {{Navbox subgroup<br />
| groupstyle = background-color: MistyRose;<br />
<br />
| group1 = [[Alpha-1 blocker|α<sub>1</sub> blocker]]s<br />
| list1 = [[Prazosin]] • [[Indoramin]] • [[Trimazosin]] • [[Doxazosin]] • [[Urapidil]]<br />
<br />
| group2 = Non-selective α blocker<br />
| list2 = [[Phentolamine]]<br />
<br />
}}<br />
<br />
}}<br />
<br />
}}<br />
<br />
| group2 = Other [[Receptor antagonist|antagonist]]s<br />
| list2 = {{Navbox subgroup<br />
| groupstyle = background:MistyRose;<br />
<br />
<br />
| group2 = [[Serotonin antagonist]]<br />
| list2 = [[Ketanserin]]<br />
<br />
| group3 = [[Endothelin receptor antagonist|Endothelin antagonist]] (for [[Pulmonary hypertension|PH]])<br />
| list3 = ''dual'' ([[Bosentan]]) • ''selective'' ([[Ambrisentan]], [[Sitaxentan]])<br />
<br />
<br />
}}<br />
<br />
<br />
<br />
| group4 = <br />
| list4 = {{PharmNavFootnote}}<br />
<br />
}}<noinclude><br />
[[Category:Drug templates|{{PAGENAME}}]]<br />
</noinclude><br />
[[Category:2Fix]]</div>
24.147.91.115